Kymera legal chief sold shares worth more than $744K
Brian Adams, Chief Legal Officer at Kymera Therapeutics, sold shares of common stock on September 4, 2026, to cover tax withholding tied to restricted stock unit vesting. Shares sold were worth over $744K.
Brian Adams, an officer serving as Chief Legal Officer, sold shares of Kymera Therapeutics common stock on September 4, 2026.
The reported transactions were sales executed to cover tax withholding obligations related to the vesting of restricted stock units.
The transactions comprised three sales o…